Neuroone Medical Technologies (NMTC) Revenue Growth (1y) (2012 - 2026)
Neuroone Medical Technologies (NMTC) Revenue Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.74% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 16.70% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.08% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 15.05% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 7.41% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 7.29% |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 | 34.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.29% |
| Dec 31, 2025 | -11.65% |
| Sep 30, 2025 | 906.64% |
| Jun 30, 2025 | 105.39% |
| Mar 31, 2025 | 0.67% |
| Dec 31, 2024 | 234.90% |
| Sep 30, 2024 | -63.29% |
| Jun 30, 2024 | 31.10% |
| Mar 31, 2024 | 195.45% |
| Dec 31, 2023 | 753.25% |
| Sep 30, 2023 | 978.36% |
| Jun 30, 2023 | 1,865.45% |
| Mar 31, 2023 | 1,174.26% |
| Dec 31, 2022 | 239.51% |
| Sep 30, 2022 | 42.31% |
| Jun 30, 2022 | -20.07% |
| Mar 31, 2022 | 100.57% |
| Dec 31, 2021 | -52.78% |
| Mar 31, 2015 | -31.52% |
| Jun 30, 2014 | -32.82% |